Theorem Clinical Research

Study Conduct

Former U.K. AstraZeneca R&D site to become science, technology park

Monday, January 20, 2014 11:56 AM

Loughborough, U.K., will be the location for a world-class science and technology park as development of a former AstraZeneca R&D site gets underway. Jayplas acquired the site in 2012 and has confirmed its plans to develop the site into a science park to be known as The Charnwood Biomedical Campus.

More... »

BIA comments on Fresh Start report

Friday, January 17, 2014 11:43 AM

Commenting on the Fresh Start report on the E.U. impact on the U.K. life science sector, Steve Bates, CEO of the BioIndustry Association (BIA), a trade association for innovative enterprises involved in U.K. bioscience, said, “This well researched report by George Freeman is right to point out that the E.U. is seen as an enlightened and progressive region for investing in biomedical research and that E.U. membership gives U.K.-based life science companies access to the single market and a uniform regulatory system for the development and approval of therapies.

More... »

Transcelerate Biopharma recognizes CCRC, CPI certification for good clinical practice

Wednesday, January 15, 2014 11:19 AM

The Association of Clinical Research Professionals (ACRP) has learned that TransCelerate Biopharma now recognizes certification through the Certified Clinical Research Coordinator (CCRC) and Certified Physician Investigator (CPI) programs of ACRP's affiliate, the Academy of Clinical Research Professionals, as evidence of Good Clinical Practice (GCP) training.

More... »

Akili Interactive Labs, Pfizer partner to test Alzheimer’s video game

Wednesday, January 15, 2014 11:00 AM

Akili Interactive Labs has entered into an agreement with Pfizer to test the ability of Akili’s mobile video game platform (Project EVO) to detect cognitive differences in healthy elderly people at risk of developing Alzheimer’s disease.

More... »

Drug company success depends on new development paradigms

Wednesday, January 8, 2014 01:23 PM

While many drug developers continue to improve clinical trial operational efficiency to increase the pace of new product introductions, their medium- and long-term success increasingly will depend on their ability to embrace more efficient R&D models, according to the Tufts Center for the Study of Drug Development.

More... »

TauRx expands Alzheimer's clinical trials in the U.S.

Monday, January 6, 2014 11:55 AM

TauRx Therapeutics, a clinical-stage biopharmaceutical company developing a novel treatment for Alzheimer's disease, has expanded its international clinical trials by adding new research centers across the U.S. The addition of 35 clinical research centers means more patients suffering from mild or moderate Alzheimer's, and their caregivers, will have an opportunity to see if they qualify for participation in TauRx's Alzheimer's clinical trials.

More... »

ideaPoint launches multi-sponsor portal

Thursday, January 2, 2014 10:35 AM

ideaPoint, a provider of partnering and collaboration systems for global enterprises, has announced the availability of a new portal providing a secure system for researchers to request access to anonymized, patient-level clinical trial data provided by sponsors ( Study sponsors who have committed to provide data through the site currently include Boehringer Ingelheim, GlaxoSmithKline, Roche, Sanofi and ViiV Healthcare.

More... »

BIA says E.U. Clinical Trial Regulation misses goal to make E.U. more attractive for trial conduct

Thursday, January 2, 2014 10:28 AM

The endorsement by the E.U. Committee of Permanent Representatives of the political agreement reached by the Lithuanian E.U. Council Presidency and the European Parliament, on the compromise text of the proposed E.U. Clinical Trials Regulation looks set to not deliver on the initial goal set by the European Commission (E.C.) when it launched the process in July 2012 of making the E.U. a more attractive location to conduct clinical trials.

More... »

EFPIA, PhRMA trial data sharing plan goes into effect

Thursday, January 2, 2014 10:22 AM

The European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA) have implemented the joint Principles for Responsible Clinical Trial Data Sharing.

More... »

Kurt+Peter Foundation builds online patient registry for muscular dystrophy

Wednesday, December 18, 2013 01:49 PM

The Kurt+Peter Foundation, a nonprofit group that supports research into potential therapies, has released the first patient registry for Limb Girdle Muscular Dystrophy, type 2C, also known as gamma sarcoglycanopathy (LGMD2C). 

More... »

Subscribe to The CenterWatch Monthly



Browse by:


September 22

Roche/Genentech plans pilot trial to measure patientpreference for participating at home v. at study site

Bipartisan 21st Century Cures initiative prepares to draft legislation to accelerate biomedical R&D, lower cost

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs